The FDA pulled its emergency use authorization for Eli Lilly’s bebtelovimab Nov. 30, which was the only monoclonal antibody treatment to be authorized for COVID-19.
Read the full post on Becker's Hospital Review - Healthcare News
FDA revokes Eli Lilly’s COVID-19 drug’s authorization
